Convertible bond

BIONIK Laboratories Announces $5 Million Capital Raise through Issuance of Convertible Notes

Retrieved on: 
Thursday, July 29, 2021

Of the $5 million, 80% comes from new investors, highlighting confidence as the Company continues to enhance its technology offerings for commercial applications.

Key Points: 
  • Of the $5 million, 80% comes from new investors, highlighting confidence as the Company continues to enhance its technology offerings for commercial applications.
  • In addition, the Company also eliminated approximately $3.9 million in total existing term loans by applying such amounts to purchase approximately $3.3 million of additional convertible promissory notes and an aggregate of 231,518 common shares of BIONIK.
  • The convertible notes have a maturity date of March 31, 2022 and convert into common stock at the maturity date.
  • BIONIK Laboratories is a robotics company focused on providing rehabilitation and mobility solutions to individuals with neurological and mobility challenges from hospital to home.

IntelGenx Announces Subscription for Notes

Retrieved on: 
Tuesday, July 27, 2021

SAINT LAURENT, Quebec, July 27, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) (the Company or IntelGenx) announces that it has received subscriptions from investors in the United States for U.S.$2.1 million principal amount of 8% convertible notes due July 31, 2025 (the Notes).

Key Points: 
  • SAINT LAURENT, Quebec, July 27, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) (the Company or IntelGenx) announces that it has received subscriptions from investors in the United States for U.S.$2.1 million principal amount of 8% convertible notes due July 31, 2025 (the Notes).
  • The Company intends to use the proceeds of the Offering to finance the Companys Montelukast study.
  • IntelGenx is a leading drug delivery company focused on the development and manufacturing of pharmaceutical films.
  • Because these forward-looking statements are subject to a number of risks and uncertainties, IntelGenx' actual results could differ materially from those expressed or implied by these forward-looking statements.

Wyloo Metals confirms its intention to convert loan

Retrieved on: 
Saturday, July 24, 2021

PERTH, Australia, July 23, 2021 (GLOBE NEWSWIRE) -- Wyloo Metals Pty Ltd. (Wyloo Metals) is pleased to provide an update in relation to the US$15 million convertible loan (the Convertible Loan) provided to Noront Resources Ltd. (TSXV:NOT) (Noront).

Key Points: 
  • PERTH, Australia, July 23, 2021 (GLOBE NEWSWIRE) -- Wyloo Metals Pty Ltd. (Wyloo Metals) is pleased to provide an update in relation to the US$15 million convertible loan (the Convertible Loan) provided to Noront Resources Ltd. (TSXV:NOT) (Noront).
  • On December 7, 2020, Wyloo Canada Holdings Pty Ltd (Wyloo Canada), a wholly-owned subsidiary of Wyloo Metals, entered into an agreement with Resource Capital Fund V L.P. (RCF) to acquire its interests in Noront, including the Convertible Loan.
  • The maturity date of the loan is September 30, 2021 and it is convertible into common shares of Noront at the option of Wyloo Metals at Cdn$0.20 per common share.
  • Wyloo Metals confirms that it intends to convert the Convertible Loan at or before the maturity date into common shares of Noront, rather than seek repayment from Noront in cash.

DGAP-News: Abivax announces the pricing of its oversubscribed capital increase of EUR 60m and convertible bonds of EUR 25m, totaling eur 85m new financing

Retrieved on: 
Friday, July 23, 2021

Abivax announces the pricing of its oversubscribed capital increase of EUR 60m and convertible bondsof EUR 25m, totaling eur 85m new financing

Key Points: 
  • Abivax announces the pricing of its oversubscribed capital increase of EUR 60m and convertible bondsof EUR 25m, totaling eur 85m new financing
    The issuer is solely responsible for the content of this announcement.
  • The additional cash needs of the Company (prior to the Transaction) for the upcoming 12 month period amount to EUR 100M, i.e.
  • In the absence of such financing, the Company could also envisage to adapt the launch timetable of the clinical trials for ABX464.
  • Bryan, Garnier & Co and J.P. Morgan AG acted as Joint Global Coordinators and Joint Bookrunners for the Capital Increase.

Life Clips Updates Shareholders On Recent Events

Retrieved on: 
Tuesday, July 20, 2021

AVENTURA, Fla., July 20, 2021 (GLOBE NEWSWIRE) -- Life Clips, Inc. (OTC Pink: LCLP) (the Company or Life Clips), today is updating shareholders on recent corporate transactions and events, including its agreement to acquire Belfrics, its information statement filing, and its Regulation A Offering.

Key Points: 
  • AVENTURA, Fla., July 20, 2021 (GLOBE NEWSWIRE) -- Life Clips, Inc. (OTC Pink: LCLP) (the Company or Life Clips), today is updating shareholders on recent corporate transactions and events, including its agreement to acquire Belfrics, its information statement filing, and its Regulation A Offering.
  • On July 9, 2021, Life Clips filed an Information Statement on Form 14C announcing a 1 for 15 reverse split of the Companys common stock.
  • Life Clips CEO Robert Grinberg continued, We appreciate all of our shareholders and considered their stake in the company when making our decision.
  • Life Clips' most recent 10-Q Quarterly report for quarter ending March 31, 2021, shows the Company has $2,428,960.00 in Convertible Notes Payable.

DGAP-News: Deutsche Rohstoff AG: Full repayment of the 2016/21 bond

Retrieved on: 
Tuesday, July 20, 2021

Deutsche Rohstoff AG will repay the maturing 2016/21 bond on schedule today.

Key Points: 
  • Deutsche Rohstoff AG will repay the maturing 2016/21 bond on schedule today.
  • This is already the second bond that Deutsche Rohstoff AG is repaying in full.
  • The debt of the Deutsche Rohstoff Group (bond and bank liabilities) currently falls to around EUR 101 million due to the repayment.
  • Outstanding are the convertible bond 2018/23 with a volume of EUR 10.7 million and the bond 2019/24 with EUR 87.1 million.

Clever Leaves Closes $25 Million Financing from SunStream

Retrieved on: 
Monday, July 19, 2021

Subject to certain limitations, SunStream may convert the principal and accrued interest on the Convertible Note into Clever Leaves common shares, without par value, at a price of $13.50 per share.

Key Points: 
  • Subject to certain limitations, SunStream may convert the principal and accrued interest on the Convertible Note into Clever Leaves common shares, without par value, at a price of $13.50 per share.
  • Further, this financing meaningfully strengthens our balance sheet and reflects our commitment to opportunistically pursue value creation opportunities for our shareholders, said Kyle Detwiler, CEO of Clever Leaves.
  • Clever Leaves was granted a license in Portugal from Infarmed the Portuguese health authority which allows Clever Leaves to cultivate, import and export dry flower for medicinal and research purposes.
  • All subsequent written and oral forward-looking statements concerning Clever Leaves and attributable to Clever Leaves or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above.

Social Life Network (OTC: WDLF) Files an Amended $43,253,342 Complaint in The United States District Court for the Southern District of California

Retrieved on: 
Monday, July 19, 2021

LOS ANGELES, CA, July 19, 2021 (GLOBE NEWSWIRE) -- Social Life Network, Inc. (OTC: WDLF), announces today that on July 16, 2021 it filed a $43,253,342 First Amended complaint against a convertible debt funder for multiple alleged federal securities laws violations.

Key Points: 
  • LOS ANGELES, CA, July 19, 2021 (GLOBE NEWSWIRE) -- Social Life Network, Inc. (OTC: WDLF), announces today that on July 16, 2021 it filed a $43,253,342 First Amended complaint against a convertible debt funder for multiple alleged federal securities laws violations.
  • Our shareholders need to know that we will not relent in our efforts to identify and pursue those who have engaged in these illegal securities activity of our stock.
  • This allows the Company to minimize its expenses and exposure to failed start-ups licensees that use its platform.
  • No information in this press release should be construed as any indication whatsoever of our future revenues, results of operations, or stock price.

Certain Virtus AllianzGI Closed-End Funds Announce Future Change In Portfolio Management Team

Retrieved on: 
Friday, July 16, 2021

HARTFORD, Conn., July 16, 2021 /PRNewswire/ --Allianz Global Investors U.S. LLC (AllianzGI), which manages certain Virtus closed-end funds in a subadvisory capacity, announced that as of March 1, 2022 Douglas G. Forsyth will step down as a co-portfolio manager of Virtus AllianzGI Convertible & Income Fund (NYSE: NCV), Virtus AllianzGI Convertible & Income Fund II (NYSE: NCZ), Virtus AllianzGI Convertible & Income 2024 Target Term Fund (NYSE: CBH), and Virtus AllianzGI Diversified Income & Convertible Fund (NYSE: ACV), Virtus AllianzGI Equity & Convertible Income Fund (NYSE: NIE), and Virtus Dividend, Interest & Premium Strategy Fund (NYSE: NFJ)

Key Points: 
  • HARTFORD, Conn., July 16, 2021 /PRNewswire/ --Allianz Global Investors U.S. LLC (AllianzGI), which manages certain Virtus closed-end funds in a subadvisory capacity, announced that as of March 1, 2022 Douglas G. Forsyth will step down as a co-portfolio manager of Virtus AllianzGI Convertible & Income Fund (NYSE: NCV), Virtus AllianzGI Convertible & Income Fund II (NYSE: NCZ), Virtus AllianzGI Convertible & Income 2024 Target Term Fund (NYSE: CBH), and Virtus AllianzGI Diversified Income & Convertible Fund (NYSE: ACV), Virtus AllianzGI Equity & Convertible Income Fund (NYSE: NIE), and Virtus Dividend, Interest & Premium Strategy Fund (NYSE: NFJ)
    There will be no changes to the investment processes for these funds, which are team oriented.
  • Virtus AllianzGI Convertible & Income Fund and Virtus AllianzGI Convertible & Income Fund II each have an investment objective to provide total return through a combination of capital appreciation and high current income with income as a secondary objective.
  • Virtus AllianzGI Diversified Income & Convertible Fund 'sinvestment objective is to provide total return through a combination of current income and capital appreciation, while seeking to provide downside protection against capital loss.
  • Virtus AllianzGI Equity & Convertible Income Fund seeks total return comprising capital appreciation, current income, and gains.

NortonLifeLock Inc. ("NortonLifeLock"): Rule 2.9 Announcement

Retrieved on: 
Thursday, July 15, 2021

NortonLifeLock does not hold any shares of common stock in treasury.

Key Points: 
  • NortonLifeLock does not hold any shares of common stock in treasury.
  • The International Securities Identification Number for NortonLifeLock's 2.000% Senior Unsecured Convertible Notes due August 2022 is US668771AA66.
  • Under Rule 8.3(a) of the Code, any person who is interested in 1 per cent.
  • Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1 per cent.